Stephen P. Macmillan - 22 Sep 2025 Form 4 Insider Report for HOLOGIC INC (HOLX)

Role
Chairman, President and CEO, Director
Signature
/s/ Mark W. Irving, attorney-in-fact for Mr. MacMillan
Issuer symbol
HOLX
Transactions as of
22 Sep 2025
Net transactions value
-$3,737,332
Form type
4
Filing time
23 Sep 2025, 16:10:08 UTC
Previous filing
18 Nov 2024
Next filing
06 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MACMILLAN STEPHEN P Chairman, President and CEO, Director 250 CAMPUS DRIVE, MARLBOROUGH /s/ Mark W. Irving, attorney-in-fact for Mr. MacMillan 23 Sep 2025 0001239351

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HOLX Common Stock Options Exercise $5,528,786 +138,358 +11% $39.96 1,372,982 22 Sep 2025 Direct F1, F2, F3
transaction HOLX Common Stock Sale $1,470,731 -22,240 -1.6% $66.13 1,350,742 22 Sep 2025 Direct F1, F2, F3, F4
transaction HOLX Common Stock Sale $5,190,103 -77,418 -5.7% $67.04 1,273,324 22 Sep 2025 Direct F1, F2, F3, F5
transaction HOLX Common Stock Sale $2,605,284 -38,700 -3% $67.32 1,234,624 22 Sep 2025 Direct F1, F2, F3, F6
holding HOLX Common Stock 1,146,829 22 Sep 2025 MacMillan Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOLX Non-qualified Stock Option (Right to Buy) Options Exercise $0 -138,358 -100% $0.000000 0 22 Sep 2025 Common Stock 138,358 $39.96 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction pursuant to an existing Rule 10b5-1 trading plan adopted December 12, 2024 to exercise and sell stock options expiring November 5, 2025.
F2 Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan.
F3 Includes 346 shares acquired pursuant to the Issuer's employee stock purchase plan since the date of the Reporting Person's most recently filed Form 4.
F4 The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $65.525 to $66.47 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
F5 The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $66.474 to $67.275 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
F6 The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $67.28 to $67.61 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
F7 This option to purchase common stock became exercisable in equal installments on each of the first four anniversaries of the grant date, November 5, 2015.